A PHASE 1/1B STUDY OF AN INHALED FORMULATION OF ITRACONAZOLE IN HEALTHY VOLUNTEERS AND ASTHMATICS
David L. Hava(Massachusetts Institute of Technology), James Roach(Pulmatrix (United States)), Lucy Connor(Wythenshawe Hospital), Adrián Curran(Lexington City Schools), Sharon Kramer(Lexington City Schools), Kuldeep Singh(All India Institute of Medical Sciences Jodhpur), Philip A. Johnson, Gary Layton(University of Geneva), David C. Henderson(Boston University), Katie Kane(Pulmatrix (United States)), D. Singh, Pauline Bedwell(Prime Minister's Office), Leonard Tan, JL Perry(Lexington City Schools)
Cited by 0
Related Papers
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
|The Lancet|2014|488
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
|Circulation|2011|375
Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
|CHEST Journal|2011|257
STARTS-2
|Circulation|2014|212